ReviewOncoTargets and therapy2025

Recent Advances in Understanding the Clinical Responses of Brentuximab Vedotin in Lymphoma and the Correlation with CD30 Expression.

Wen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.